Scantox is a preclinical GLP-accredited CRO specializing in Discovery, Regulatory Toxicology, and Pharmaceutical Development & Analytical services. With headquarters in Ejby, Denmark, and subsidiaries in Lund, Gothenburg, Solna, Ballerup, and Austria, Scantox is a trusted partner in the pharmaceutical and medical devices industries. Founded in 1977 and owned by the Nordic investment company Impilo, Scantox is passionate about improving health through rigorous scientific standards. Certified as a Great Place To Work™ in 2023, Scantox embodies dedication and purpose in all its services and operations.
Visit Company Website
